The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Subscribe To Our Newsletter & Stay Updated
